These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 35351965)

  • 21. Piperlongumine-inhibited TRIM14 signaling sensitizes glioblastoma cells to temozolomide treatment.
    Kuo YY; Ho KH; Shih CM; Chen PH; Liu AJ; Chen KC
    Life Sci; 2022 Nov; 309():121023. PubMed ID: 36202175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long non-coding RNA ATXN8OS promotes ferroptosis and inhibits the temozolomide-resistance of gliomas through the ADAR/GLS2 pathway.
    Luo J; Bai R; Liu Y; Bi H; Shi X; Qu C
    Brain Res Bull; 2022 Aug; 186():27-37. PubMed ID: 35460867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PSMG3-AS1 enhances glioma resistance to temozolomide via stabilizing c-Myc in the nucleus.
    Zhou L; Huang X; Zhang Y; Wang J; Li H; Huang H
    Brain Behav; 2022 May; 12(5):e2531. PubMed ID: 35380741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The miR-26a/AP-2α/Nanog signaling axis mediates stem cell self-renewal and temozolomide resistance in glioma.
    Huang W; Zhong Z; Luo C; Xiao Y; Li L; Zhang X; Yang L; Xiao K; Ning Y; Chen L; Liu Q; Hu X; Zhang J; Ding X; Xiang S
    Theranostics; 2019; 9(19):5497-5516. PubMed ID: 31534499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-147a Targets SLC40A1 to Induce Ferroptosis in Human Glioblastoma.
    Xu P; Ge FH; Li WX; Xu Z; Wang XL; Shen JL; Xu AB; Hao RR
    Anal Cell Pathol (Amst); 2022; 2022():2843990. PubMed ID: 35942174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Role Played by SLUG, an Epithelial-Mesenchymal Transition Factor, in Invasion and Therapeutic Resistance of Malignant Glioma.
    Oh SJ; Ahn EJ; Kim O; Kim D; Jung TY; Jung S; Lee JH; Kim KK; Kim H; Kim EH; Lee KH; Moon KS
    Cell Mol Neurobiol; 2019 Aug; 39(6):769-782. PubMed ID: 31011939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. H-ferritin suppression and pronounced mitochondrial respiration make Hepatocellular Carcinoma cells sensitive to RSL3-induced ferroptosis.
    Asperti M; Bellini S; Grillo E; Gryzik M; Cantamessa L; Ronca R; Maccarinelli F; Salvi A; De Petro G; Arosio P; Mitola S; Poli M
    Free Radic Biol Med; 2021 Jun; 169():294-303. PubMed ID: 33892112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RSL3 Drives Ferroptosis through NF-
    Li S; He Y; Chen K; Sun J; Zhang L; He Y; Yu H; Li Q
    Oxid Med Cell Longev; 2021; 2021():2915019. PubMed ID: 34987700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme.
    Li Z; Zhang J; Zheng H; Li C; Xiong J; Wang W; Bao H; Jin H; Liang P
    J Exp Clin Cancer Res; 2019 Aug; 38(1):380. PubMed ID: 31462285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells.
    Maciaczyk D; Picard D; Zhao L; Koch K; Herrera-Rios D; Li G; Marquardt V; Pauck D; Hoerbelt T; Zhang W; Ouwens DM; Remke M; Jiang T; Steiger HJ; Maciaczyk J; Kahlert UD
    Br J Cancer; 2017 Jun; 117(1):102-112. PubMed ID: 28571041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TRPML2 Mucolipin Channels Drive the Response of Glioma Stem Cells to Temozolomide and Affect the Overall Survival in Glioblastoma Patients.
    Morelli MB; Nabissi M; Amantini C; Maggi F; Ricci-Vitiani L; Pallini R; Santoni G
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-128-3p Enhances the Chemosensitivity of Temozolomide in Glioblastoma by Targeting c-Met and EMT.
    Zhao C; Guo R; Guan F; Ma S; Li M; Wu J; Liu X; Li H; Yang B
    Sci Rep; 2020 Jun; 10(1):9471. PubMed ID: 32528036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD90
    Xue BZ; Xiang W; Zhang Q; Wang HF; Zhou YJ; Tian H; Abdelmaksou A; Xue J; Sun MX; Yi DY; Xiong NX; Jiang XB; Zhao HY; Fu P
    Stem Cell Res Ther; 2021 Jul; 12(1):394. PubMed ID: 34256854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poly(ADP-ribose) polymerase inhibitor increases growth inhibition and reduces G(2)/M cell accumulation induced by temozolomide in malignant glioma cells.
    Tentori L; Portarena I; Torino F; Scerrati M; Navarra P; Graziani G
    Glia; 2002 Oct; 40(1):44-54. PubMed ID: 12237842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exosomal transfer of miR-151a enhances chemosensitivity to temozolomide in drug-resistant glioblastoma.
    Zeng A; Wei Z; Yan W; Yin J; Huang X; Zhou X; Li R; Shen F; Wu W; Wang X; You Y
    Cancer Lett; 2018 Nov; 436():10-21. PubMed ID: 30102952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long non-coding RNA KB-1460A1.5 promotes ferroptosis by inhibiting mTOR/SREBP-1/SCD1-mediated polyunsaturated fatty acid desaturation in glioma.
    Xu L; Wen B; Wu Q; Lu S; Liao J; Mo L; Li Q; Tong X; Yan H
    Carcinogenesis; 2024 Jul; 45(7):487-499. PubMed ID: 38422369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TFR2 regulates ferroptosis and enhances temozolomide chemo-sensitization in gliomas.
    Tong S; Hong Y; Xu Y; Sun Q; Ye L; Cai J; Ye Z; Chen Q; Tian D
    Exp Cell Res; 2023 Mar; 424(1):113474. PubMed ID: 36702193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulsed and Discontinuous Electromagnetic Field Exposure Decreases Temozolomide Resistance in Glioblastoma by Modulating the Expression of O
    Dehghani-Soltani S; Eftekhar-Vaghefi SH; Babaee A; Basiri M; Mohammadipoor-Ghasemabad L; Vosough P; Ahmadi-Zeidabadi M
    Cancer Biother Radiopharm; 2021 Sep; 36(7):579-587. PubMed ID: 32644826
    [No Abstract]   [Full Text] [Related]  

  • 39. Transcriptional control of O
    Happold C; Stojcheva N; Silginer M; Weiss T; Roth P; Reifenberger G; Weller M
    J Neurochem; 2018 Mar; 144(6):780-790. PubMed ID: 29480969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploring the Mechanism of Adjuvant Treatment of Glioblastoma Using Temozolomide and Metformin.
    Feng SW; Chang PC; Chen HY; Hueng DY; Li YF; Huang SM
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.